Author

Karl Balabanian

InsermORCID 0000-0002-0534-3198Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Marion EspéliiD· 2 shared Vanessa Gourhand· 2 shared Amélie BonaudiD· 1 shared Camilla JandusiD· 1 shared Clémentine MouliniD· 1 shared Daniel A. BenamraniD· 1 shared Emilie LereclusiD· 1 shared Emma DespondsiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Marion EspéliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

Emma Desponds, Hajar El Ahanidi, Nagham Alouche, Hana Zdimerova, Stéphanie Favre, Giulio Zanette, Sina Nassiri, Daniel A. Benamran, Petros K. Tsantoulis, Mohammed Attaleb, Hélène Maby-El Hajjami, Julien Dagher, Vanessa Gourhand, Karl Balabanian, Marion Espéli, , Grégory Verdeil

This study identifies CXCR4-expressing tumor-associated macrophages in bladder cancer and shows that targeting them improves immunotherapy outcomes in mice and patients.

bioRxiv · Mar 21, 2025 · PreprintImmunology

Plasma cell heterogeneity is driven by type of immune challenge

Mélanie Khamyath, Emilie Lereclus, Vanessa Gourhand, Pierre-Édouard Debureaux, Clémentine Moulin, Hélène Gary‐Gouy, Françoise Bachelerie, Karl Balabanian, Marion Espéli, Amélie Bonaud

This study identifies five plasma cell subsets in humans and mice, showing their heterogeneity is driven by immune challenge type and B cell origin.

bioRxiv · Mar 26, 2024 · PreprintImmunology